Related Experiment Video

Updated: May 7, 2026

Extraction and Analysis of Taiwanese Green Propolis
06:50

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

Olive leaf extracts are a natural source of advanced glycation end product inhibitors

Vassiliki G Kontogianni1, Pantelis Charisiadis, Evangelia Margianni

  • 11 Department of Chemistry, University of Ioannina , Ioannina, Greece .

Journal of Medicinal Food
|September 19, 2013
PubMed

Insights

Methanolic olive leaf extract effectively inhibits advanced glycation end product (AGE) formation, a key factor in diabetic complications. Specific compounds like luteolin show potent anti-glycation activity, highlighting the importance of extraction methods.

Area of Science:

  • Phytochemistry
  • Biochemistry
  • Pharmacology

Background:

  • Advanced glycation end products (AGEs) accumulate during hyperglycemia and contribute to diabetic complications.
  • Inhibiting AGE formation is a promising therapeutic strategy for managing diabetes.
  • Olive leaves are a potential source of bioactive compounds for AGE inhibition.

Purpose of the Study:

  • To investigate the phytochemical composition of olive leaf extracts.
  • To evaluate the in vitro effect of aqueous and methanolic olive leaf extracts on AGE formation.
  • To identify specific compounds responsible for anti-glycation activity.

Main Methods:

  • Phytochemical profiling using LC/DAD/ESI-MS(n).
  • Quantification of phenolic compounds via HPLC-UV/Vis and NMR spectroscopy.
  • In vitro AGE inhibition assay using bovine serum albumin (BSA) with ribose or fructose.

Main Results:

  • Methanolic olive leaf extract significantly inhibited fluorescent AGE formation in a BSA-ribose system.
  • Aqueous olive leaf extract showed no significant effect on AGE formation.
  • Luteolin and luteolin-4'-O-β-D-glucopyranoside were identified as potent AGE formation inhibitors.

Conclusions:

  • The extraction method significantly influences the phytochemical composition and anti-glycation potential of olive leaf extracts.
  • Methanolic extraction yields compounds effective in inhibiting AGE formation.
  • Olive leaf-derived compounds, particularly luteolin and its glucoside, represent potential agents for preventing diabetic complications.

More Related Videos

Microwave-Assisted Extraction of Phenolic Compounds and Antioxidants for Cosmetic Applications Using Polyol-Based Technology07:05

Microwave-Assisted Extraction of Phenolic Compounds and Antioxidants for Cosmetic Applications Using Polyol-Based Technology

Published on: August 23, 2024

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...